[Best medical treatment of lower extremity arterial disease in 2018]

Giacomo Buso1, Luca Calanca1, Barbara Ney1

  • 1Service d'angiologie, CHUV, 1011 Lausanne.

Revue Medicale Suisse
|December 6, 2018
PubMed

Insights

Lower extremity artery disease (LEAD) causes disability and increases cardiovascular risk. Optimal medical treatment involves lifestyle changes and medications to manage risk factors effectively.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Health
  • Public Health

Background:

  • Lower extremity artery disease (LEAD) is prevalent and leads to significant disability.
  • LEAD is strongly linked to increased cardiovascular morbidity and mortality.
  • Patients with LEAD face substantial functional limitations.

Purpose of the Study:

  • To emphasize the critical role of optimal medical treatment in managing lower extremity artery disease.
  • To highlight the comprehensive approach required for effective clinical management.
  • To underscore the importance of risk factor control in LEAD patients.

Main Methods:

  • Management of cardiovascular risk factors is central to treatment.
  • Lifestyle modifications, including healthy living and physical activity, are key.
  • Pharmacological interventions (antihypertensives, lipid-lowering, antidiabetics, antithrombotics) are essential when indicated.

Main Results:

  • Optimal medical treatment significantly impacts patient outcomes.
  • Comprehensive risk factor management reduces morbidity and mortality.
  • Structured physical activity improves patient functioning.

Conclusions:

  • Optimal medical treatment is fundamental for patients with lower extremity artery disease.
  • Clinicians must prioritize risk factor management in all LEAD patients.
  • A multi-faceted approach combining lifestyle and medication is crucial for effective care.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
956
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
358
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
380
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455